Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation.

Subjects

Subjects :

Adenocarcinoma of Lung enzymology
Adenocarcinoma of Lung genetics
Adenocarcinoma of Lung pathology
Adult
Aminopyridines
Female
Humans
Lactams
Lung Neoplasms genetics
Lung Neoplasms pathology
Mutation
Point Mutation
Pyrazoles
Adenocarcinoma of Lung drug therapy
Anaplastic Lymphoma Kinase genetics
Lactams, Macrocyclic therapeutic use
Lung Neoplasms drug therapy
Lung Neoplasms enzymology

Details

Language :

English

ISSN :

1556-1380

Volume :

13

Issue :

8

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Report

Accession number :

30049377

Full Text :

https://doi.org/10.1016/j.jtho.2018.03.017